Deep Tissue Imaging Applications Poised to Contribute Over 15% Market Share by 2021, as Multiphoton Microscopy Demand Grows

2021-08-16
并购合作
Multiphoton Microscopy to Gain Traction at 5% CAGR as Advanced Technologies Make Inroads in Cancer Screening The multiphoton microscopy market study by Fact.MR presents incisive view of the key growth drivers and restraints impacting the market through 2031. The survey offers multiphoton microscopy demand outlook and studies opportunities existing in key segments, including type and end user. It also highlights key strategies adopted by market players to increase multiphoton microscopy sales. Fact.MR – A Market Research and Competitive Intelligence Provider: As per insights by Fact.MR, the global market for multiphoton microscopy is expected grow at a CAGR of nearly 5% over the forecast period 2021-2031, owing to the increasing adoption of multiphoton microscopy in the cancer research centres. Rising prevalence of cancer is fuelling the demand for early diagnosis and treatment, which is further expected to propel growth of the multiphoton microscopy market. Likewise, multiphoton microscopy is gaining significant popularity across the globe owing to its features including, deep penetration in tissues, reduced photo damage, useful in live cell imaging and reduced out-of-focus bleaching. Among various applications, deep tissue imaging is anticipated to channel majority of revenue, accounting for over 16% of the market share in 2021. Demand will continue increasing due to the various advantages of this imaging technique, which specifically includes initial diagnosis, staging, and monitoring of treatment response. Consequently, the market will witness rising scope for applications in cancer screening programs. Request a report sample to gain comprehensive insights at Some of the leading market players are increasingly focusing on new product offerings and innovative techniques for diagnosis, including 3D reconstructed image of live cells, high-resolution, high-sensitivity, deep multiphoton imaging, multi wavelength excitation for broader spectral coverage, and software optimized for multiphoton. This in turn will create lucrative opportunities for growth of the market. The U.S. market for multiphoton microscopy will remain dominant. Demand outlook for the U.S. remains positive driven by rising incidence of cancer, favourable healthcare policies and increasing healthcare spending. “With increasing penetration of technological innovations and novel product launches, the market for multiphoton microscopy is expected to surge at a rapid pace. Also, two-photon microscopy is gaining immense popularity, which will further bolster future growth prospects,” says a Fact.MR analyst. Key Takeaways from Multiphoton Microscopy Market Survey Driven by growing healthcare spending, the U.S. market for multiphoton microscopy is expected to emerge as a highly lucrative pocket over the forecast period. The U.K. market for multiphoton microscopy is poised to grow at a steady rate owing to the rising prevalence of cancer. Based on application, the deep tissue imaging will account for over 16% of the market revenue in 2021. Key Drivers Innovative techniques and products manufactured for diagnosis are likely to drive the growth of the market. Favourable reimbursement scenarios for research and development in multiphoton microscopy will support the growth of the market. Key Restraints High cost of multiphoton microscopic devices is expected to hinder the market growth. Lack of skilled professionals to operate instruments will hamper sales prospects. To learn more about Multiphoton Microscopy Market, you can get in touch with our Analyst at: Competitive Landscape Several multiphoton microscopy manufacturers are focusing on new product launches to consolidate their footprint. Other companies are also emphasizing on acquisitions to gain a competitive edge. For instance, in 2020, HORIBA, a global leader in Raman microscopy and nanoscopy announced the launch of its new imaging tool named EasyImageTM. It offers assistance to new users, allowing them to rapidly produce publication-ready results. In 2020, ZEISS announced the acquisition of Arivis AG. With this acquisition, ZEISS is focusing at solidifying its software expertise in image processing, 3D image visualization and analysis software for research microscopy. Some of the leading players operating in the multiphoton microscopy market profiled by Fact.MR are: Olympus Corporation Bruker Leica Microsystems (Danhar) Nikon ZEISS Thorlabs, Inc Lavision Biotech Semrock Becker & Hickl GmbH Scientifica (Judges Scientific plc) Sutter Instrument Femtonics Ltd More Valuable Insights on Multiphoton Microscopy Market Fact.MR, in its new report, offers an unbiased analysis of the global multiphoton microscopy market, analyzing forecast statistics through 2021 and beyond. the survey reveals growth projections on multiphoton microscopy market with detailed segmentation: Product Two-photon Microscopy Three-photon Microscopy Application Skin Imaging Neuroscience Oncology Immunology Immunology Deep Tissue Imaging Functional and Molecular Imaging Intravital Imaging Cell Culture Virology Others End User Hospitals & Clinics Clinical & Diagnostic Laboratories Academic & Research Institutes Region North America Latin America Europe South Asia East Asia Oceania Middle East and Africa Key Questions Covered in the Multiphoton Microscopy Market Report The market survey also highlights projected sales growth for multiphoton microscopy market between 2021 and 2031 The report offers insight into multiphoton microscopy demand outlook for forecast period 2021-2031 Multiphoton microscopy market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others Multiphoton microscopy market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry Explore Fact.MR’s Coverage on the Healthcare Domain – Microscopy Devices Market- The number of contract research organizations (CROs) has increased dramatically, expanding the market for microscopy devices. This is due to the fact that all large corporations are outsourcing their research and development in order to concentrate more on their core business divisions and cut costs elsewhere. These CROs help these businesses undertake laboratory research that require the use of microscopes. The global microscopy devices market is poised to be exploited significantly based on these developments. The demand for more penetrative mediums to identify cells has accelerated microscopic device development. Scanning Probe Microscopes Market- Manufacturers are increasingly choosing equipment with cutting-edge technical features to perform research studies on various biological and non-biological elements in order to produce novel solutions. Furthermore, due to the growing necessity for providing in-depth information and expertise, the demand for technologically equipped microscopes at various educational institutions continues to rise. During the forecast period, the necessity for failure analysis to maintain proper functioning of electronic devices is projected to have an impact on the worldwide scanning probe microscope market's growth. X-ray Microscopes Market- The market for X-ray microscopes will be driven by increasing demand for medical imaging. The market is predicted to be driven by a growth in the prevalence of orthopaedic, neurology, and cardiovascular diseases, which would necessitate the use of better imaging techniques for diagnosis and treatment. Furthermore, when compared to other medicines available on the market, X-ray technology appears to be cost effective. X-ray microscopes come with a few drawbacks as well. Over the projected period, the market for X-ray microscopes is expected to rise due to precision treatment, an ageing population, and changing lifestyles. About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Reach out to us with your goals, and we’ll be an able research partner. Contact: Mahendra Singh US Sales Office 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E: sales@factmr.com Source: Fact.MR
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。